Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples